plasminogen activator inhibitor

基本解釋

• 纖溶酶原激活物抑制劑

英漢例句

雙語(yǔ)例句

• The high-phenol group also experienced a greater drop in the activity of another clot promoter, plasminogen activator inhibitor-1.
  高酚早餐組另一血栓促進(jìn)因子——纖維蛋白溶酶原活化抑制因子-1的活性也呈現(xiàn)顯著降低。
• Objective To study the relationship of plasminogen activator inhibitor type 1(PAI 1) to platelet activity in elderly patients with unstable angina pectoris(UAP).
  目的探討老年不穩(wěn)定型心絞痛（UAP）與纖溶酶原激活物抑制劑1型（PAI 1）及血小板活化功能的臨牀意義。
• Plasminogen activator inhibitor-1 (PAI-1) is one of the important components of the plasma fibrinolytic system and plays an key role in maintaining its stability.
  纖溶酶原激活物抑制物1（PAI-1）是血漿纖維蛋白溶解系統(tǒng)的重要組成物之一，對(duì)維持血漿纖溶系統(tǒng)的穩(wěn)定起重要作用。

• plasminogen activator inhibitor更多例句

詞組短語(yǔ)

短語(yǔ)

• human plasminogen -activator inhibitor type 人纖溶酶原激活物抑制物
• activator plasminogen activator inhibitor 纖溶酶原激活劑及其抑制物
• human plasminogen activator inhibitor 人pai
• plasminogen activator inhibitor activity 血漿纖溶酶原激活物抑制劑
• plasminogen activator in inhibitor 纖溶酶原激活劑

• plasminogen activator inhibitor更多詞組

專業(yè)釋義

毉葯科學(xué)

• 纖溶酶原激活劑抑制劑

  It has been reported that fibrinolytic dysfunction caused by variation in the activity and concentration of tissue plasminogen activator (t - PA ) and plasminogen activator inhibitor - 1 ( PAI -1) seems to be related to atherosclerosis and thrombosis.
  研究表明，血液中組織型纖溶酶原激活劑(t-PA)和纖溶酶原激活劑抑制劑-1(PAI-1)活性或含量的變化導(dǎo)致的纖溶活性減低與冠狀動(dòng)脈粥樣硬化及血栓形成和延展有關(guān)。

• 纖溶酶原抑制劑
• 纖溶酶原活化物抑制劑

  Objectives: To find out the effects of estrogen and progestin on the activity and mRNA expression of tissue-type plasminogen activator(tPA) and plasminogen activator inhibitor -1 (PAI-1) in human umbilical vein endothelial cells (HUVEC).
  目的：觀察雌孕激素對(duì)人臍靜脈內(nèi)皮細(xì)胞(HUVEC)組織型纖溶酶原激活劑(tPA)、纖溶酶原活化物抑制劑-1(PAI-1)的活性及其基因表達(dá)的影響。

  生物學(xué)

• 纖溶酶原活化物抑制劑
• 纖溶酶原激活物抑制劑

計(jì)算機(jī)科學(xué)技術(shù)

• 纖溶酶原激活物抑制劑